APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. - Wikidata - awgldk - TriplyDB

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

http://www.wikidata.org/entity/Q34351034

about

Apolipoprotein E gene polymorphisms are associated with primary hyperuricemia in a Chinese population Genetic determinants of arterial stiffness.Roles of fasting and postprandial blood glucose in the effect of type 2 diabetes on central arterial stiffness: a 5-year prospective community-based analysis.Human plasma lipid modulation in schistosomiasis mansoni depends on apolipoprotein E polymorphism Association between genetic variants in the Coenzyme Q10 metabolism and Coenzyme Q10 status in humans SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men.Mechanobiological stability: a new paradigm to understand the enlargement of aneurysms?The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.Impact of APOE gene polymorphisms on the lipid profile in an Algerian population.E2 allele of the apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia.CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population.Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy.Studies of gene variants related to inflammation, oxidative stress, dyslipidemia, and obesity: implications for a nutrigenetic approach MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy.A Common APOE Polymorphism Is an Independent Risk Factor for Reduced Glomerular Filtration Rate in the Spanish RENASTUR Cohort.Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population.CD36 haplotypes are associated with lipid profile in normal-weight subjects.Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation.Apolipoprotein E gene polymorphism and serum lipid profile in Saudi patients with psoriasis.Type of LDLR mutation and the pharmacogenetics of familial hypercholesterolemia treatment.Effect of docosahexaenoic acid and furan fatty acids on cytokinesis block micronucleus cytome assay biomarkers in astrocytoma cell lines under conditions of oxidative stress.Studying the role of ApoE in Alzheimer's disease pathogenesis using a systems biology model.Gene-environment interaction in Alzheimer's disease.Is there any association of apolipoprotein E gene polymorphisms with metabolic syndrome in a young population of Croatian origin?APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease.CYP2C9 and VKORC1 polymorphisms influence warfarin dose variability in patients on long-term anticoagulation.Association between the C242T polymorphism in the p22phox gene with arterial stiffness in the Brazilian population.SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia.

P2860

Q28544622-4925201C-5C49-4BDB-AE84-963DB814FEB0 Q30301168-CBA0DB27-4E2F-47C5-A552-9E0592167BFE Q33667869-C6F7FDF1-9AA0-4642-B5BC-29B339AC4CB7 Q33933106-73A00E8E-6527-49B6-86F9-9A8D721DAED2 Q33966562-9C617238-DAC1-4F9F-91D4-4F35A62D438C Q34047278-1897E909-DC28-44FB-BE50-2B10D5B859D5 Q34277421-BBEA0309-69A7-4F5B-BF43-4C282EDD8537 Q34311880-0403DA7E-1317-4093-87F9-8CDB1A0E0C43 Q34387744-A7ED2C3D-8076-4A59-9F18-83299EF41290 Q34508651-9718E500-82DA-4E1F-985A-323774073000 Q34515304-FC2A87A3-31F4-48A5-A1D5-89FC5A195066 Q34552473-FE8818C6-190B-4234-82CC-093D6EA4655D Q34809332-0A3F59E6-DF08-460B-883D-FA26EEEBBF53 Q35104849-6FB3F7D0-2B90-4F50-B8E2-F9318F8FAEAC Q36226649-13BF563F-801C-4EE6-AE34-98996C427E1D Q36293981-91360C15-F695-426C-85C8-DBBC83C885B8 Q37039745-E4D45680-3F3F-4C2D-9D02-B737EC49B961 Q37065825-A1F5817B-6542-4B7A-925F-BAAB140A1DFE Q37152130-B296750F-85B8-4748-83F0-E4E95D2A0C09 Q37348385-E08F9148-65A7-4218-8F3E-C978601AECF3 Q37516941-DD2FFF14-16AC-4CAD-AE60-87EEF1A75403 Q37693885-D635535F-02EE-4713-AEF8-9081D501FE40 Q38596963-BF3C6BA7-0242-4C10-83C5-3701FBFD0C7A Q38994921-F932EA93-B062-41EA-9BD4-F037C5DEE906 Q39331556-D0BFCABA-FACB-41B2-AB56-5D29EF142065 Q39567162-44DBDB4F-CFD8-4E17-99F9-6C9A0EDCECF8 Q40662832-86DAC3F7-4182-438E-B7F7-AF148AC79581 Q51327331-0B27BE01-CA35-46A6-AE59-0CD8884BAF4C Q53123523-179DA7C4-EA4B-408F-B8B1-3B7110FF0283 Q54315032-B540708E-9BF8-4EF7-B8D8-45E664FEBB9C Q54559255-033EB604-DBCC-41D7-B4D5-115F56239C8B

P2860

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population.

http://www.wikidata.org/entity/Q34351034

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

APOE polymorphism is associate ...... ess in the general population.

@ast

APOE polymorphism is associate ...... ess in the general population.

@en

APOE polymorphism is associate ...... ess in the general population.

@nl

type

label

APOE polymorphism is associate ...... ess in the general population.

@ast

APOE polymorphism is associate ...... ess in the general population.

@en

APOE polymorphism is associate ...... ess in the general population.

@nl

prefLabel

APOE polymorphism is associate ...... ess in the general population.

@ast

APOE polymorphism is associate ...... ess in the general population.

@en

APOE polymorphism is associate ...... ess in the general population.

@nl

P1433

Q34351034-DE3EE9F1-FC98-4054-A23A-624D5AA90832

P1476

Q34351034-94A95753-FCF2-4B7E-AE21-C53A29111285

P2093

Q34351034-3663CB5A-9B25-4883-BFC5-D91B5F2E1933

Q34351034-52124689-D64D-4799-A2BC-931148083846

Q34351034-81721823-170F-46E5-893C-61E8D8969DAA

Q34351034-9E246B14-49C8-45C8-9F37-8D9286A442EF

Q34351034-CCA7FB92-1480-42E6-AEE4-08B46136C19C

Q34351034-D590B049-59A1-40CA-A431-1DFE5D931887

Q34351034-D729F5CA-4AF1-4150-A8C3-CD46B08B36CC

Q34351034-F4445518-97F5-42AB-8B1F-0DFA8F7C21BB

P2860

Q34351034-08CE2CF0-D976-4DAF-BDF3-8B6E729B8DB2

Q34351034-0C9ED4B8-554F-4844-960F-ED47F761A879

Q34351034-0D6F7936-21E4-41CB-8149-63B09A87EC88

Q34351034-11D9F413-6D5A-4A60-93C9-8B95415FE541

Q34351034-2453ACF5-AAB3-4202-8538-D13AFFD83EA7

Q34351034-275D65A2-EE8B-4E51-9746-FA3E32A92215

Q34351034-37D02A71-B176-4AA7-BC98-4C5DF7570754

Q34351034-4389F95D-BBB9-4D26-BDCB-8BF4F0528031

Q34351034-44C06966-3241-4DE3-ADB6-CE095A6157B6

Q34351034-49EF0C71-7386-4FFB-A6D9-FE5817C7147C

P2888

Q34351034-7F4FC068-6987-454C-A669-5A8B56A8DCE5

P304

Q34351034-17D16EC3-6CA6-4BF9-89DE-64E0885A30F6

P31

Q34351034-1CF04D99-5DBE-4434-B90D-E05506D82B4D

P356

Q34351034-3190178D-37BD-447A-A275-CF665863E8EB

P478

Q34351034-1ED7DFFD-BACD-49D7-9214-C6276CB90886

P577

Q34351034-B86A3ACA-F2C4-4193-A53A-E4E3EE332C7D

P6179

Q34351034-B5F45094-F69A-4FD4-8F90-8941DE0B280A

P698

Q34351034-D6608BA5-6B90-44F5-866E-077064E96A28

P932

Q34351034-BA634951-199C-4F6C-991F-C6701F78AAC5

P356

1476-511X-9-128

P1433

Lipids in Health and Disease

P1476

APOE polymorphism is associate ...... ess in the general population.

@en

P2093

Alexandre C Pereira

http://www.w3.org/2001/XMLSchema#string

José E Krieger

http://www.w3.org/2001/XMLSchema#string

José G Mill

http://www.w3.org/2001/XMLSchema#string

Noely E Ferreira

http://www.w3.org/2001/XMLSchema#string

Paulo C J L Santos

http://www.w3.org/2001/XMLSchema#string

Rafael O Alvim

http://www.w3.org/2001/XMLSchema#string

Roberto S Cunha

http://www.w3.org/2001/XMLSchema#string

Silvia R S Freitas

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Plasma lipoproteins: apolipoprotein structure and function

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

A simple salting out procedure for extracting DNA from human nucleated cells

Apolipoprotein E and coronary disease: a puzzling paradox.

Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population.

Clinical review 141: lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies.

Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype.

Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.

P2888

1476-511x-9-128

P304

128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-511X-9-128

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1047530166

http://www.w3.org/2001/XMLSchema#string

P698

21059196

http://www.w3.org/2001/XMLSchema#string

P932

2992057

http://www.w3.org/2001/XMLSchema#string